Delivery Order SPE2DR25D3012-SPE2DR26F4E2T
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,516.36 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with an ultimate completion date of December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,085.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with performance completion targeted for November 3, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injectors valued at $1,400.67. This firm fixed-price delivery order, with an ultimate completion date of November 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,272.07 on August 6, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,086.44 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector pharmaceutical product on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,436.85 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on December 30, 2025, with completion scheduled for December 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio supporting federal medical procurement. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units valued at $2,223.86 under a firm fixed price contract. The delivery order, which is a child contract under a larger vehicle, specifies a completion date of September 23, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This award was not designated as a set-aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.70 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies, with a completion date of December 11, 2025. This non-competitive delivery order is issued under a firm fixed-price contract structure and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The product will be performed and delivered from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.38 to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector supplies on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,922.98 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injector syringes. This firm fixed-price delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-set-aside, competitively awarded procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E2TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units valued at $1,722.90, with an ultimate completion date of January 2, 2026. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed from the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is part of AmerisourceBergen Drug Corp's extensive engagement with the Defense Logistics Agency's Medical Supply Chain, supported by a prime IDC valued at $999,999,999.00 and extending through December 2026. The company supplies a comprehensive range of pharmaceutical products and medical devices to support military healthcare systems, veteran programs, and other federal customers. AmerisourceBergen's role in the DLA's pharmaceutical supply chain reflects its capability to fulfill federal medical requirements through open competition, demonstrating the company's position as a critical vendor for military and federal healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/30/25 |